Back to Search Start Over

MLL2mutation detection in 86 patients with Kabuki syndrome: a genotype-phenotype study

Authors :
B. van Lier
Luis A. Pérez-Jurado
Alexander Hoischen
Periklis Makrythanasis
I. van der Burgt
Ann Nordgren
Alexandre Reymond
Britt-Marie Anderlid
M. del Campo
Ivon Cuscó
L. Toledo
Jacqueline Schoumans
C. M. Kets
B W M van Bon
Michael A. Simpson
M. Ruiterkamp-Versteeg
Juliette Dupont
Margherita Silengo
E. Frysira
L. Izatt
Lucia Micale
Willie Reardon
Stavroula Psoni
Patricia Dias
Helger G. Yntema
Nicole Revencu
Joris A. Veltman
Bartolomeo Augello
Juliane Hoyer
Isabel Cordeiro
Tony Roscioli
Giuseppe Merla
Ernie M.H.F. Bongers
M. Bhat
Christian Gilissen
Stylianos E. Antonarakis
H. G. Santos
E. Galan
Elisa Biamino
Peer Arts
Blanca Gener
Shehla Mohammed
A. M. Cueto-Gonzalez
Marloes Steehouwer
Richard C. Trembath
Carlo Marcelis
B. B. A. de Vries
Christiane Zweier
Han G. Brunner
B. Rodriguez-Santiago
Raquel Flores
Charu Deshpande
Janneke H M Schuurs-Hoeijmakers
S. A. de Munnik
Ana Medeira
Teresa Vendrell
David A. Koolen
S. M. Granneman
Source :
Clinical Genetics. 84:539-545
Publication Year :
2013
Publisher :
Wiley, 2013.

Abstract

Recently, pathogenic variants in the MLL2 gene were identified as the most common cause of Kabuki (Niikawa-Kuroki) syndrome (MIM#147920). To further elucidate the genotype-phenotype correlation, we studied a large cohort of 86 clinically defined patients with Kabuki syndrome (KS) for mutations in MLL2. All patients were assessed using a standardized phenotype list and all were scored using a newly developed clinical score list for KS (MLL2-Kabuki score 0-10). Sequencing of the full coding region and intron-exon boundaries of MLL2 identified a total of 45 likely pathogenic mutations (52%): 31 nonsense, 10 missense and four splice-site mutations, 34 of which were novel. In five additional patients, novel, i.e. non-dbSNP132 variants of clinically unknown relevance, were identified. Patients with likely pathogenic nonsense or missense MLL2 mutations were usually more severely affected (median 'MLL2-Kabuki score' of 6) as compared to the patients without MLL2 mutations (median 'MLL2-Kabuki score' of 5), a significant difference (p

Details

ISSN :
00099163
Volume :
84
Database :
OpenAIRE
Journal :
Clinical Genetics
Accession number :
edsair.doi...........39eaa9d360ba5272c5f971c1f5c02e9a